ETHealthworld.com brings latest multiple sclerosis news, views and updates from all top sources for the Indian Health industry.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. In October 2024, news broke that Facebook parent company Meta had cracked an "impossible" problem ...

Finally, a family friend who worked as a healthcare provider in urgent care took her concerns seriously, ordered tests, and asked if she’d ever had an MRI. Within a month, Chelsea had her first scan ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X The film tells the tale of Sydney Price (Kelly) and Henri Cassell (Wozniczka), who have a ...

Champagne Problems is one of Netflix’s Hallmark-style holiday romances, but with its stellar cast, a hilarious script, and some actually sexy moments between the lead actors, it’s an even better ...

Willowy romantic comedies are a dime-a-dozen at Christmastime, but the only complaints are coming from people who don’t like Christmas rom-coms in the first place. This genre’s fans aren’t looking to ...

Isabella Soares is a Senior Writer for Collider, as well as a Cherry Picks-approved critic. A film and TV enthusiast from an early age, Isabella used to write reviews in her journal growing up, which ...

Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...

Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

We may receive a commission on purchases made from links. Technology, no matter how advanced it is, is never perfect. With every type of smart device or gadget comes some sort of issue that users have ...

That’s how Meta’s chief AI scientist Yann LeCun described the blowback after OpenAI researchers did a victory lap over GPT-5’s supposed math breakthroughs. Google DeepMind CEO Demis Hassabis added, ...